Canada markets close in 5 hours 40 minutes

Regulus Therapeutics Inc. (RGLS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.3100+0.0100 (+0.43%)
As of 10:19AM EDT. Market open.
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-30,037
-30,037
-28,323
-27,808
-15,730
Depreciation & amortization
227
227
122
459
467
Stock based compensation
2,801
2,801
2,177
2,923
2,614
Change in working capital
257
257
550
914
-41
Accounts Payable
29
29
-110
-250
-786
Other working capital
-27,381
-27,381
-25,887
-24,379
-12,547
Other non-cash items
141
141
133
46
154
Net cash provided by operating activites
-26,768
-26,768
-25,526
-24,128
-12,536
Cash flows from investing activities
Investments in property, plant and equipment
-613
-613
-361
-251
-11
Purchases of investments
-4,899
-4,899
-32,759
0
-
Sales/Maturities of investments
20,000
20,000
18,000
0
-
Net cash used for investing activites
14,491
14,491
-15,120
-251
-11
Cash flows from financing activities
Debt repayment
-3,304
-3,304
0
-80
-10,277
Common stock issued
15,120
15,120
4,491
53,791
19,123
Net cash used privided by (used for) financing activities
11,816
11,816
4,491
53,737
9,513
Net change in cash
-461
-461
-36,155
29,358
-3,034
Cash at beginning of period
24,290
24,290
60,445
31,087
34,121
Cash at end of period
23,829
23,829
24,290
60,445
31,087
Free Cash Flow
Operating Cash Flow
-26,768
-26,768
-25,526
-24,128
-12,536
Capital Expenditure
-613
-613
-361
-251
-11
Free Cash Flow
-27,381
-27,381
-25,887
-24,379
-12,547